Executive Summary
Azoth Analytics has released a research named "Global Colorectal Cancer (CRC) Screening Market (2023 Edition)" which provides a complete analysis of the global Colorectal Cancer (CRC) Screening industry in terms of segmentation by Screening Type (Stool-based Tests, Flexible Sigmoidoscopy, Colonoscopy, CT Colonography - Virtual Colonoscopy, Other Screening Type), By End-use (Hospitals & Clinics, Clinical Laboratories, Diagnostic Imaging Centers) for the historical period of 2019-2022, estimated year of 2023 and the forecast period of 2024-2029.
The research is global in nature and covers a detailed analysis of the market in America (U.S., Canada, Brazil, Rest of Americas), Europe (Germany, U.K., France, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Rest of Asia-Pacific), and Middle-east and Africa. Additionally, the research report displays data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
During the forecast period, 2024-2029, the global Colorectal Cancer (CRC) Screening market is expected to expand at a CAGR of 7%. Ageing populations, rising CRC incidence with age, preference for healthy living, increased awareness of the severity of cancers, rising bowel cancer incidence, rising prevalence of disease, and increased government policies for CRC screening in an effort to reduce diseases globally are some of the key factors influencing demand for colorectal cancer screening globally.
The Global Colorectal Cancer (CRC) Screening Market is expected to generate USD 27.7 billion by the end of 2029, up from USD 17.2 billion in 2022. Some of the key factors driving demand for Colorectal Cancer (CRC) Screening globally include rising disposable incomes, urbanization, an unhealth lifestyle, westernization, a preference for leading healthy lifestyles, increased consumer awareness of the severity of digestive disorders, stomach pain, willingness to pay a high price for cancer screening and treatment, and market accessibility of various screening & tests.
Additionally, Colorectal Cancer (CRC) Screening sales are being positively boosted by enhanced new product development and strong promotional actions by key manufacturers & diagnostic labs. The rising prevalence of colorectal cancer is one of the major factors driving the market growth. Some other factors include for the growth of the colorectal cancer screening the advent of efficacious genetic tests, an increase in the prevalence of colorectal cancer, and increasing cancer prevention initiatives.
One of the main drivers fueling the Colorectal Cancer Screening Market; the increasing incidence of colorectal cancer. An estimated 1,019,000 new instances of cancer, including 158,200 new cases of colorectal cancer, were expected in Japan in 2022, according to data offered by the National Cancer Centre Japan in June 2022. Similar to this, it was estimated that 15,713 new cases of colorectal cancer would be identified in Australia in 2022, out of which 8,300 were male and 7,413 were female, according to data updated by Cancer Australia in August 2022.
Colonoscopy is one of the most common procedures performed, with about 14.2 million procedures carried out alone in the United States. Data on national trends imply an increase in CRC screening rates, which is nearly completely related to more people having colonoscopies. Therefore, it is expected that the use of colonoscopy (CRC Screening) equipment will increase as colorectal cancer rates rise.
Companies in the Colorectal Cancer (CRC) Screening market are placing stakes on R&D investments and new product releases as patient become more aware about cancer and innovative trends emerge quickly. Companies are paying close attention to value-added offerings as long as healthcare specialists continue to recommend increasing the screening tests as a way to go for the better treatment and improve long-term health. The potential of Colorectal Cancer (CRC) Screenings in products is being systematically investigated by large brand firms as well as small high-tech startups, which may signal new beginnings for market players.
The study profiles leading players in the Global Colorectal Cancer (CRC) Screening Market including Olympus Corporation, EXACT Sciences Corporation, Quest Diagnostics, QuidelOrtho Corporation, Fujifilm Holdings Corporation, Eiken Chemical Co. Ltd, BioMerieux SA, Epigenomics AG, Siemens Healthineers, Danaher Corporation, and others. The company profiling includes critical information such as a business overview, products and services, key financials, and recent events and developments. Overall, the report provides a detailed overview of the Global Colorectal Cancer (CRC) Screening Market, which will assist industry consultants, medical equipment manufacturers, existing players looking for expansion opportunities, new players looking for opportunities, and other stakeholders in aligning their market-centric strategies with current and expected future trends.
Scope of the Report:
• The report analyses the Colorectal Cancer Screening Market by Value (USD Million)
• The report analyses the Colorectal Cancer Screening Market by Number of Screenings (in Million).
• The report presents the analysis of Colorectal Cancer Screening market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Colorectal Cancer Screening Market by Screening Type (Stool-based Tests, Flexible Sigmoidoscopy, Colonoscopy, CT Colonography (Virtual Colonoscopy), Other Screening Type).
• The report analyses the Colorectal Cancer Screening Market by End-use (Hospitals & Clinics, Clinical Laboratories, Diagnostic Imaging Centers).
• The Global Colorectal Cancer Screening Market has been analysed by countries (United States, Canada, Brazil, Germany, United Kingdom, France, China, Japan, India, South Korea).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Colorectal Cancer Screening Type and by End-use.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include are Olympus Corporation, EXACT Sciences Corporation, Quest Diagnostics, QuidelOrtho Corporation, Fujifilm Holdings Corporation, Eiken Chemical Co. Ltd, BioMerieux SA, Epigenomics AG, Siemens Healthineers, Danaher Corporation.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
2.1 Focusing on Early Detection Technologies
2.2 Patient education and awareness campaigns
3. Global Colorectal Cancer Screening Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on Colorectal Cancer Screening Market
3.2 Global Colorectal Cancer Screening Market: Ecosystem Analysis
3.2.1 Epidemiology Of Colorectal Cancer
3.2.2 Colorectum Cancer Statistics
3.3 Global Colorectal Cancer Screening Market: Dashboard
3.4 Global Colorectal Cancer Screening Market: Market Value Assessment, 2019-2029 (USD Million)
3.5 Global Colorectal Cancer Screening Market: Number of Screenings
3.6 Average Screening Cost Analysis of Colorectal Cancer Screening Market
3.7 Impact of COVID-19 on Colorectal Cancer Screening Market
3.8 Global Colorectal Cancer Screening Market Segmentation: By Screening Type
3.8.1 Global Colorectal Cancer Screening Market, By Screening Type Overview
3.8.2 Global Colorectal Cancer Screening Market Size, By Stool-based Tests, By Value, 2019H-2029F (USD Million & CAGR)
3.8.3 Global Colorectal Cancer Screening Market Size, By Flexible Sigmoidoscopy, By Value, 2019H-2029F (USD Million & CAGR)
3.8.4 Global Colorectal Cancer Screening Market Size, By Colonoscopy, By Value, 2019H-2029F (USD Million & CAGR)
3.8.5 Global Colorectal Cancer Screening Market Size, By CT Colonography (Virtual Colonoscopy), By Value, 2019H-2029F (USD Million & CAGR)
3.8.6 Global Colorectal Cancer Screening Market Size, By Other Screening Type, By Value, 2019H-2029F (USD Million & CAGR)
3.9 Global Colorectal Cancer Screening Market Segmentation: By End-use
3.9.1 Global Colorectal Cancer Screening Market, By End-use Overview
3.9.2 Global Colorectal Cancer Screening Market Size, By Hospitals & Clinics, By Value, 2019H-2029F (USD Million & CAGR)
3.9.3 Global Colorectal Cancer Screening Market Size, By Clinical Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
3.9.4 Global Colorectal Cancer Screening Market Size, By Diagnostic Imaging Centers, By Value, 2019H-2029F (USD Million & CAGR)
4. Global Colorectal Cancer Screening Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Colorectal Cancer Screening Market: Historic and Forecast (2019-2029)
5.1 Americas Colorectal Cancer Screening Market: Snapshot
5.2 Americas Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.3 Americas Colorectal Cancer Screening Market: Number of Screenings
5.4 Americas Colorectal Cancer Screening Market: Key Factors
5.5 Americas Colorectal Cancer Screening Market Segmentation: By Screening Type
5.5.1 Americas Colorectal Cancer Screening Market, By Screening Type Overview
5.5.2 Americas Colorectal Cancer Screening Market Size, By Stool-based Tests, By Value, 2019H-2029F (USD Million & CAGR)
5.5.3 Americas Colorectal Cancer Screening Market Size, By Flexible Sigmoidoscopy, By Value, 2019H-2029F (USD Million & CAGR)
5.5.4 Americas Colorectal Cancer Screening Market Size, By Colonoscopy, By Value, 2019H-2029F (USD Million & CAGR)
5.5.5 Americas Colorectal Cancer Screening Market Size, By CT Colonography (Virtual Colonoscopy), By Value, 2019H-2029F (USD Million & CAGR)
5.5.6 Americas Colorectal Cancer Screening Market Size, By Other Screening Type, By Value, 2019H-2029F (USD Million & CAGR)
5.6 Americas Colorectal Cancer Screening Market Segmentation: By End-use
5.6.1 Americas Colorectal Cancer Screening Market, By End-use Overview
5.6.2 Americas Colorectal Cancer Screening Market Size, By Hospitals & Clinics, By Value, 2019H-2029F (USD Million & CAGR)
5.6.3 Americas Colorectal Cancer Screening Market Size, By Clinical Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
5.6.4 Americas Colorectal Cancer Screening Market Size, By Diagnostic Imaging Centers, By Value, 2019H-2029F (USD Million & CAGR)
5.7 Americas Colorectal Cancer Screening Market Segmentation : By Country
5.7.1 United States Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.1.1 United States Colorectal Cancer Screening Market, By Screening Type
5.7.1.2 United States Colorectal Cancer Screening Market, By End-use
5.7.2 Canada Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.2.1 Canada Colorectal Cancer Screening Market, By Screening Type
5.7.2.2 Canada Colorectal Cancer Screening Market, By End-use
5.7.3 Brazil Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.3.1 Brazil Colorectal Cancer Screening Market, By Screening Type
5.7.3.2 Brazil Colorectal Cancer Screening Market, By End-use
5.7.4 Rest of Americas Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.7.4.1 Rest of Americas Colorectal Cancer Screening Market, By Screening Type
5.7.4.2 Rest of Americas Colorectal Cancer Screening Market, By End-use
6. Europe Colorectal Cancer Screening Market: Historic and Forecast (2019-2029)
6.1 Europe Colorectal Cancer Screening Market: Snapshot
6.2 Europe Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.3 Europe Colorectal Cancer Screening Market: Number of Screenings
6.4 Europe Colorectal Cancer Screening Market: Key Factors
6.5 Europe Colorectal Cancer Screening Market Segmentation: By Screening Type
6.5.1 Europe Colorectal Cancer Screening Market, By Screening Type Overview
6.5.2 Europe Colorectal Cancer Screening Market Size, By Stool-based Tests, By Value, 2019H-2029F (USD Million & CAGR)
6.5.3 Europe Colorectal Cancer Screening Market Size, By Flexible Sigmoidoscopy, By Value, 2019H-2029F (USD Million & CAGR)
6.5.4 Europe Colorectal Cancer Screening Market Size, By Colonoscopy, By Value, 2019H-2029F (USD Million & CAGR)
6.5.5 Europe Colorectal Cancer Screening Market Size, By CT Colonography (Virtual Colonoscopy), By Value, 2019H-2029F (USD Million & CAGR)
6.5.6 Europe Colorectal Cancer Screening Market Size, By Other Screening Type, By Value, 2019H-2029F (USD Million & CAGR)
6.6 Europe Colorectal Cancer Screening Market Segmentation: By End-use
6.6.1 Europe Colorectal Cancer Screening Market, By End-use Overview
6.6.2 Europe Colorectal Cancer Screening Market Size, By Hospitals & Clinics, By Value, 2019H-2029F (USD Million & CAGR)
6.6.3 Europe Colorectal Cancer Screening Market Size, By Clinical Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
6.6.4 Europe Colorectal Cancer Screening Market Size, By Diagnostic Imaging Centers, By Value, 2019H-2029F (USD Million & CAGR)
6.7 Europe Colorectal Cancer Screening Market Segmentation : By Country
6.7.1 Germany Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.1.1 Germany Colorectal Cancer Screening Market, By Screening Type
6.7.1.2 Germany Colorectal Cancer Screening Market, By End-use
6.7.2 United Kingdom Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.2.1 United Kingdom Colorectal Cancer Screening Market, By Screening Type
6.7.2.2 United Kingdom Colorectal Cancer Screening Market, By End-use
6.7.3 France Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.3.1 France Colorectal Cancer Screening Market, By Screening Type
6.7.3.2 France Colorectal Cancer Screening Market, By End-use
6.7.4 Rest of Europe Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.7.4.1 Rest of Europe Colorectal Cancer Screening Market, By Screening Type
6.7.4.2 Rest of Europe Colorectal Cancer Screening Market, By End-use
7. Asia-pacific Colorectal Cancer Screening Market: Historic and Forecast (2019-2029)
7.1 Asia-pacific Colorectal Cancer Screening Market: Snapshot
7.2 Asia-pacific Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.3 Asia-pacific Colorectal Cancer Screening Market: Number of Screenings
7.4 Asia-pacific Colorectal Cancer Screening Market: Key Factors
7.5 Asia-pacific Colorectal Cancer Screening Market Segmentation : By Screening Type
7.5.1 Asia-pacific Colorectal Cancer Screening Market, By Screening Type Overview
7.5.2 Asia-pacific Colorectal Cancer Screening Market Size, By Stool-based Tests, By Value, 2019H-2029F (USD Million & CAGR)
7.5.3 Asia-pacific Colorectal Cancer Screening Market Size, By Flexible Sigmoidoscopy, By Value, 2019H-2029F (USD Million & CAGR)
7.5.4 Asia-pacific Colorectal Cancer Screening Market Size, By Colonoscopy, By Value, 2019H-2029F (USD Million & CAGR)
7.5.5 Asia-pacific Colorectal Cancer Screening Market Size, By CT Colonography (Virtual Colonoscopy), By Value, 2019H-2029F (USD Million & CAGR)
7.5.6 Asia-pacific Colorectal Cancer Screening Market Size, By Other Screening Type, By Value, 2019H-2029F (USD Million & CAGR)
7.6 Asia-pacific Colorectal Cancer Screening Market Segmentation : By End-use
7.6.1 Asia-pacific Colorectal Cancer Screening Market, By End-use Overview
7.6.2 Asia-pacific Colorectal Cancer Screening Market Size, By Hospitals & Clinics, By Value, 2019H-2029F (USD Million & CAGR)
7.6.3 Asia-pacific Colorectal Cancer Screening Market Size, By Clinical Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
7.6.4 Asia-pacific Colorectal Cancer Screening Market Size, By Diagnostic Imaging Centers, By Value, 2019H-2029F (USD Million & CAGR)
7.7 Asia-pacific Colorectal Cancer Screening Market Segmentation : By Country
7.7.1 China Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.1.1 China Colorectal Cancer Screening Market, By Screening Type
7.7.1.2 China Colorectal Cancer Screening Market, By End-use
7.7.2 Japan Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.3.1 Japan Colorectal Cancer Screening Market, By Screening Type
7.7.3.2 Japan Colorectal Cancer Screening Market, By End-use
7.7.3 India Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.3.1 India Colorectal Cancer Screening Market, By Screening Type
7.7.3.2 India Colorectal Cancer Screening Market, By End-use
7.7.4 South Korea Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.4.1 South Korea Colorectal Cancer Screening Market, By Screening Type
7.7.4.2 South Korea Colorectal Cancer Screening Market, By End-use
7.7.5 Rest of Asia-pacific Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.7.5.1 Rest of Asia-pacific Colorectal Cancer Screening Market, By Screening Type
7.7.5.2 Rest of Asia-pacific Colorectal Cancer Screening Market, By End-use
8. Middle-east & Africa Colorectal Cancer Screening Market: Historic and Forecast (2019-2029)
8.1 Middle-east & Africa Colorectal Cancer Screening Market: Snapshot
8.2 Middle-east & Africa Colorectal Cancer Screening Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
8.3 Middle-east & Africa Colorectal Cancer Screening Market: Number of Screenings
8.4 Middle-east & Africa Colorectal Cancer Screening Market: Key Factors
8.5 Middle-east & Africa Colorectal Cancer Screening Market Segmentation : By Screening Type
8.5.1 Middle-east & Africa Colorectal Cancer Screening Market, By Screening Type Overview
8.5.2 Middle-east & Africa Colorectal Cancer Screening Market Size, By Stool-based Tests, By Value, 2019H-2029F (USD Million & CAGR)
8.5.3 Middle-east & Africa Colorectal Cancer Screening Market Size, By Flexible Sigmoidoscopy, By Value, 2019H-2029F (USD Million & CAGR)
8.5.4 Middle-east & Africa Colorectal Cancer Screening Market Size, By Colonoscopy, By Value, 2019H-2029F (USD Million & CAGR)
8.5.5 Middle-east & Africa Colorectal Cancer Screening Market Size, By CT Colonography (Virtual Colonoscopy), By Value, 2019H-2029F (USD Million & CAGR)
8.5.6 Middle-east & Africa Colorectal Cancer Screening Market Size, By Other Screening Type, By Value, 2019H-2029F (USD Million & CAGR)
8.6 Middle-east & Africa Colorectal Cancer Screening Market Segmentation : By End-use
8.6.1 Middle-east & Africa Colorectal Cancer Screening Market, By End-use Overview
8.6.2 Middle-east & Africa Colorectal Cancer Screening Market Size, By Hospitals & Clinics, By Value, 2019H-2029F (USD Million & CAGR)
8.6.3 Middle-east & Africa Colorectal Cancer Screening Market Size, By Clinical Laboratories, By Value, 2019H-2029F (USD Million & CAGR)
8.6.4 Middle-east & Africa Colorectal Cancer Screening Market Size, By Diagnostic Imaging Centers, By Value, 2019H-2029F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Colorectal Cancer Screening Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Macro-Economic Factor Assessment
10.2 Value Chain Analysis
10.3 Porter's Five Forces Model
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Colorectal Cancer Screening Market
11.4 Company Profiles
11.4.1 Olympus Corporation
11.4.2 EXACT Sciences Corporation
11.4.3 Quest Diagnostics
11.4.4 QuidelOrtho Corporation
11.4.5 BioMerieux SA
11.4.6 Fujifilm Holdings Corporation
11.4.7 Eiken Chemical Co. Ltd
11.4.8 Epigenomics AG
11.4.9 Siemens Healthineers
11.4.10 Danaher Corporation
Request Sample 
Request Discount 
Inquire Before Buy
